MABioN December Webinar – Safety Games 2 – 12/01/25

MABioN December Webinar – Safety Games 2 – 12/01/25

On Monday, December 1, 2025, MABioN is hosting a FREE webinar, Safety Games 2!

The webinar will be from 9-10 AM (Central Time)/ 10-11 AM (Eastern)

In 2024, the University of Michigan (U-M) Medical School rolled out a lab safety awareness contest for research laboratories. A quiz was developed that included questions related to biological and chemical research and addressed frequent and/or high-risk inspection deficiencies and incidents on the medical campus. Prizes were chosen that supported and improved safety in the areas the quiz covered. There will be time for Q&A.

MABioN December Webinar – Safety Games 2 – 12/01/25

MABioN Webinar – Too Shy to Ask the Listserv: Biosafety Modernization Edition – 10/15/25

FREE Webinar – Wednesday, Oct 15, 2025 12pm CDT, 1pm EDT

It’s never been more important for biosafety professionals and institutions to submit questions! This webinar will begin with a brief presentation explaining the process. It will also encourage all shareholders to prepare to submit comments to the NIH to amplify the voices of biosafety in this process. This will be an interactive, open forum discussion without a formal panel. Participants can submit questions anonymously with their registration or live during the webinar.

MABioN December Webinar – Safety Games 2 – 12/01/25

Considerations for Working with LCMV – From Bench to Bedside

Lymphocytic choriomeningitis virus (LCMV) is a single-stranded RNA arenavirus commonly used in laboratory animal models to examine acute and chronic viral infections and immunopathology. However, there is wide variation in LCMV biosafety practices between...
MABioN December Webinar – Safety Games 2 – 12/01/25

June 6, 2023 1pm CT | MABioN Webinar: Clinical Gene Transfer/Gene Therapy Biosafety and Compliance

MABioN is proud to offer a webinar discussing

Clinical gene transfer/gene therapy biosafety and compliance

This webinar will be a panel discussion of the topic.

IBC oversight of studies involving transfer of recombinant DNA/RNA or recombinant micro-organisms to human research study subjects can be complex. We will review the NIH guidelines that apply to human research and benchmark how different institutions handle IBC approvals. There will be a panel discussion on institutional experiences of hearing gene therapy studies using an internal IBC vs. using a third-party (external) IBC.

MABioN December Webinar – Safety Games 2 – 12/01/25

Nov 15, 2022 noon CT | MABioN Webinar: Retooling: Adapting HAZWOPER to a biomedical academic research institution

MABioN is proud to offer a webinar discussing
Retooling: Adapting HAZWOPER to a biomedical academic research institution

This presentation will describe how HAZWOPER hazardous material training can be geared to fit the needs of individuals working in an academic research institution

Presented By: John C. Bivona

University of Chicago
Director of Biosafety and Biosecurity,
Select Agent Alternate Responsible Official

John received his Bachelor of Science from Illinois State University, with an emphasis in Environmental Health and Safety (EHS), in 1994. He began his career working for an EHS consultant and then in 2000 was hired by University of Chicago EHS, where he served for eight years in multiple roles including Industrial Hygienist, EHS Officer, and Biosafety Officer/Alternate Responsible Official for the Select Agent Program.He currently serves as the primary point of contact for the UChicago Select Agent Program at the Howard Taylor Ricketts Laboratory (HTRL), which is located on the campus of Argonne National Laboratory.

John oversees all aspects of biosafety, biosecurity and incident response, including all communications related to the program, both internally within the program and externally with the Centers for Disease Control and Prevention and U.S. Department of Agriculture. John has numerous other certifications, including OSHA 40 – Hour HAZMAT, OSHA Hazardous Material Handling, OSHA 510 – Standards for General Industry, and First Receiver Decontamination for Hospitals and FEMA Incident Command Systems for Health Care Organizations.